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We analyzed by multilocus sequence typing 77 lym-
phogranuloma venereum Chlamydia trachomatis strains 
from men who have sex with men in Europe and the United 
States. Specimens from an outbreak in 2003 in Europe were 
monoclonal. In contrast, several strains were in the United 
States in the 1980s, including a variant from Europe.
Lymphogranuloma venereum (LGV) is a sexually trans-mitted disease caused by Chlamydia trachomatis se-
rovars L1, L2, and L3. This disease is endemic to parts of 
Africa, Latin America, and Asia but only occurred sporadi-
cally in Europe before 2003, at which time an outbreak of 
LGV occurred in the Netherlands among men who have 
sex with men (MSM) (1). Since then, a large number of 
LGV cases have been reported among MSM in Europe, 
North America, and Australia. Although the inguinal form 
(formation of buboes) is more common in heterosexual 
LGV patients, in the current epidemic among MSM, anal 
infections have been diagnosed in most LGV cases.
Sequencing the highly variable outer membrane pro-
tein A (ompA) gene identified a new genetic variant des-
ignated L2b, which subsequently has been identified in 
nearly all recent LGV cases in MSM that have been inves-
tigated (2). This variant was also found in isolates obtained 
from MSM in San Francisco, California, USA, in the early 
1980s (3). However, differences in other regions of the C. 
trachomatis genome are possible and these regions should 
be investigated.
Multilocus sequence typing (MLST) is a genotyping 
method based on amplification and sequencing of several 
genetic regions. Recently, 3 MLST systems for genotyp-
ing of Chlamydiacae bacteria have been reported. Two are 
based on housekeeping genes, and their resolution is com-
parable to that of ompA (4,5), which gives these 2 systems 
limited usefulness in C. trachomatis strain discrimination 
and outbreak investigations. A third MLST system was 
reported by Klint et al. (6) for short-term epidemiologic 
analysis of C. trachomatis strains. This system showed 
a 3-fold higher resolution than conventional ompA geno-
typing when applied to serovars A–K (6,7), which cause 
ocular trachoma and genital chlamydia infections. Recent 
evaluation of typing schemes confirms the considerable 
discriminatory potential of our system and recommends it 
for typing of closely related clinical strains (8). This system 
includes 5 highly variable gene regions; 2 of them (penicil-
lin-binding protein and histone H1–like protein [hctB]), are 
subjected to selection pressure, which facilitates analysis of 
epidemiologic changes over limited periods.
Our objective was to deduce the nature and origin of 
the LGV outbreak among MSM in Europe. We used the 
MLST system of Klint et al. (6) to investigate genetic 
variation in LGV strains. Strains were obtained from MSM 
from contemporary Europe and the United States and from 
MSM in San Francisco during the 1980s.
The Study
All LGV specimens were obtained from MSM attend-
ing outpatient clinics. Twenty-two specimens were obtained 
in San Francisco during 1979–1985, and 5 specimens were 
obtained in the Baltimore, MD–Washington, DC, USA, 
area during 2007–2009. Fifty specimens were obtained 
from patients in Europe (Denmark [n = 7], France [n = 15], 
Germany [n = 1], the Netherlands [n = 9], Norway [n = 2], 
Spain [n = 7], and Sweden [n = 9]) during 2004–2008. DNA 
purification, PCR amplification of the ompA gene and the 5 
specific highly variable gene regions (by using high-fidelity 
polymerase), DNA sequencing, and analysis of data (mean 
5,972 nt/specimen, primers excluded) were performed as 
described (6,9). All novel mutations were reamplified and 
resequenced to confirm their authenticity.
All except 1 of the 50 specimens from Europe had an 
ompA genotype identical to the L2b reference strain L2b/
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UCH-1/proctitis (AM884177.1). The nonidentical specimen 
came from Spain and had a previously unpublished single 
C→T point mutation in variable segment 2 at position 517 
when compared with L2b/UCH-1/proctitis. This sequence 
of this specimen has been deposited in GenBank (accession 
no. GQ413955). All 50 specimens from Europe shared an 
identical MLST genotype (Table). The 5 specimens from 
the contemporary United States had the same ompA and 
MLST genotype as specimens from Europe (Table).
The 22 specimens from San Francisco were separated 
into 3 ompA genotypes and 5 MLST genotypes (Table). 
Six specimens had an ompA genotype identical to the L2 
reference strain L2/434/Bu, and 7 had a novel genotype 
that differed from the L1 reference strain L1/440 by 9 point 
mutations. The remaining 9 specimens had an ompA geno-
type identical those of specimens from Europe and L2b ref-
erence strain L2b/UCH-1/proctitis. Three of these 9 speci-
mens had MLST genotypes of strains from Europe, and the 
other 6 had a novel 108-nt deletion in the hctB gene region. 
This hctB variant has not been found in other specimens of 
C. trachomatis serovars A–L3 and is unique in the MLST 
database (http://mlstdb.bmc.uu.se/), which contains genetic 
profiles for 496 specimens (February 2010).
Conclusions
We aimed to deduce the nature and origin of the LGV 
outbreak among MSM in Europe. Because of the conserved 
nature of Chlamydia spp. genomes, high-resolution geno-
typing, rather than following evolutionary changes over 
long periods as with conventional MLST systems, was es-
sential for investigating this outbreak. We found that the 
high-resolution MLST system described by Klint et al. (6) 
was most suitable for the current study.
LGV specimens from MSM in Europe in this study 
were monoclonal for ompA and the 5 highly variable re-
gions. This finding suggests a single source of origin for 
the LGV outbreak among MSM in Europe. One specimen 
in this study contained a novel, single, point mutation in 
ompA. In 373 contemporary LGV cases in MSM in the 
United Kingdom, the L2b ompA variant comprised >90% 
of the specimens, and the remaining 35 specimens belonged 
to 4 novel sequence variants, each differing from the L2b 
variant by a single point mutation (10). These single point 
mutations might have occurred recently, and their presence 
is less likely to indicate a separate source of origin.
LGV specimens from MSM in the 1980s in San Fran-
cisco showed genetic variation in ompA and the 5 highly 
variable gene regions. MLST analysis showed that 6 of the 
9 specimens from San Francisco that had the L2b ompA 
variant were genetically different from the strain in Europe; 
the remaining 3 specimens had an MLST profile identical 
to that of the variant from Europe. Genetic variation among 
LGV specimens from San Francisco supports the idea that 
LGV is endemic in MSM in the United States, a finding 
that has been reported (11).
In contrast, the epidemiologic pattern and genetic char-
acterization of LGV in several countries in Europe indicate 
that the L2b type has disseminated across Europe in recent 
years. In Sweden, 3 LGV cases that produced clinical signs 
were detected in 2004 and 2005 (12). In a survey of 81% of 
patients with C. trachomatis infection detected among high 
risk MSM in Stockholm, no additional LGV cases were de-
tected (12), and a total of 15 LGV cases were detected in 
2007. If one considers the highly internationalized network 
of sexual contacts among MSM (13), the L2b variant may 
have been imported to Europe from the United States. A 
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Table. Genetic profiles of lymphogranuloma venereum specimens, Europe and United States* 
Location Sample years 
No.
specimens
MLST profile 
ompAhctB CT058 CT144 CT172 pbpB
Europe† 2004–2009 49 27 13 17 13 29 28‡
Europe§ 2004–2009 1 27 13 17 13 29 39¶
USA# 2007–2009  5 27 13 17 13 29 28‡
USA** 1979–1985 3 27 13 17 13 29 28‡
USA** 1979–1985 6 44†† 13 17 13 29 28‡
USA** 1979–1985 7 18 13 23 13 29 40‡‡ 
USA** 1979–1985 5 18 13 19 6 28 22§§ 
USA** 1979–1985 1 18 37 19 6 28 22§§ 
*MLST, multilocus sequence typing; hctB, histone H1–like protein; pbpB, penicillin-binding protein; ompA, outer membrane protein A. Values are arbitrary 
designations referring to allele variants in our Chlamydia trachomatis MLST database (http://mlstdb.bmc.uu.se/). All MLST variants differ within regions 
with <5 point mutations unless otherwise indicated. 
†Denmark (n = 7), France (n = 15), Germany (n = 1), the Netherlands (n = 9), Norway (n = 2), Spain (n = 6), and Sweden (n = 9).
‡ompA variant 28 is identical to the reference strain L2b/UCH-1/proctitis (AM884177.1). 
§Spain.
¶ompA variant 39 contains a single point mutation compared with L2b/UCH-1/proctitis and has been deposited in GenBank under accession no. 
GQ413955. 
#Baltimore, Maryland–Washington, DC. 
**San Francisco, California. 
††hctB variant 44 contains a novel 108-nt deletion and is unique in the MLST database. 
‡‡ompA variant 40 contains 9 point mutations compared with reference strain L1/440 (DQ064294.1) and has been deposited in GenBank under 
accession no. GQ413956. 
§§ompA variant 22 is identical to reference strain L2/434/Bu (AM884176.1). 
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limitation of our study is that it does not include old LGV 
strains from Europe. However, after widespread investiga-
tions, we believe that no such strains are available.
Our study shows that the MLST system of Klint et al. 
(6) is suitable for epidemiologic analysis of C. trachomatis 
transmission, as indicated by our ability to differentiate the 
L2b ompA variant found in San Francisco into 2 strains. In-
vestigation of additional LGV specimens from the United 
States and regions to which LGV is endemic with the MLST 
system could help determine a more detailed epidemiologic 
picture of the LGV outbreak in 2003 among MSM.
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